CAPRONI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 458
EU - Europa 286
AS - Asia 147
Continente sconosciuto - Info sul continente non disponibili 2
Totale 893
Nazione #
US - Stati Uniti d'America 458
IT - Italia 93
IE - Irlanda 83
SG - Singapore 43
CN - Cina 34
HK - Hong Kong 30
UA - Ucraina 26
VN - Vietnam 25
FI - Finlandia 18
DE - Germania 17
RU - Federazione Russa 14
FR - Francia 10
TR - Turchia 6
GB - Regno Unito 5
SE - Svezia 5
KR - Corea 4
NL - Olanda 4
CZ - Repubblica Ceca 3
LB - Libano 3
PL - Polonia 3
AT - Austria 2
BE - Belgio 2
EU - Europa 2
CH - Svizzera 1
KZ - Kazakistan 1
UZ - Uzbekistan 1
Totale 893
Città #
Chandler 131
Dublin 83
San Mateo 43
Boardman 39
Singapore 37
Perugia 35
Hong Kong 30
Altamura 26
Dong Ket 25
Santa Clara 21
Beijing 19
Dearborn 18
Medford 18
Princeton 18
Lawrence 17
Jacksonville 12
Wilmington 12
Andover 9
Des Moines 9
Ann Arbor 7
Izmir 6
Florence 5
Rome 4
Saint Petersburg 4
Seoul 4
Brno 3
Helsinki 3
Milan 3
Munich 3
Naples 3
Norwalk 3
San Paolo di Civitate 3
Ashburn 2
Brussels 2
Den Haag 2
Falls Church 2
Frankfurt Am Main 2
Jesi 2
Taranto 2
Terni 2
Almaty 1
City Of Industry 1
Dallas 1
Falconara Marittima 1
Falkenstein 1
Fiesole 1
Guangzhou 1
Hefei 1
Kiev 1
Lappeenranta 1
Lausanne 1
Los Angeles 1
Lurano 1
Moscow 1
Mountain View 1
Ningbo 1
Redwood City 1
Southwell 1
Tappahannock 1
Woodbridge 1
Zibido San Giacomo 1
Totale 690
Nome #
Migraine-specific quality of life questionnaire and relapse of medication overuse headache 72
Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache 58
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 58
Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study 58
Migraine with aura in the locker room: three case reports. 56
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 56
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 56
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 54
Palinopsia in patients with migraine: a case-control study. 52
Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial. 52
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 51
Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study 46
Migraine and epilepsy: what value today? 45
HDAC3 role in medication consumption in medication overuse headache patients: A pilot study 45
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 44
null 39
Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system. 34
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. 30
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 20
Totale 926
Categoria #
all - tutte 4.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 7 12 12 6 7 13 1 0
2020/202190 0 6 0 4 39 0 5 5 3 0 3 25
2021/2022132 1 30 3 3 2 3 2 45 0 5 20 18
2022/2023340 20 78 5 39 32 33 0 8 112 1 9 3
2023/2024121 11 10 12 1 0 0 30 2 0 4 16 35
2024/2025102 9 20 32 15 26 0 0 0 0 0 0 0
Totale 926